Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Empress Therapeutics Launches with $50M

2023-07-01
CAMBRIDGE, MA, Flagship Pioneering, the bioplatform innovation company, unveiled Empress Therapeutics with $50 million commitment.
CAMBRIDGE, MA, Flagship Pioneering, the bioplatform innovation company, unveiled Empress Therapeutics. Empress's proprietary Chemilogics product platform creates drugs by understanding how the genetic code programs cells in the human body to produce chemical compounds called metabolites, a rich source of potential small molecule medicines. Flagship has made an initial commitment of $50 million to support the development of Empress's platform and the company's initial pipeline of drug candidates.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors